NCT04909554View on ClinicalTrials.gov

MRI-based Approaches for Multi-parametric Model to Early Predict Pathological Complete Response to Neoadjuvant Therapy in Breast Cancer

CompletedOBSERVATIONAL

Enrollment

301

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

July 30, 2023

Study Completion Date

December 30, 2023

Conditions

Breast Cancer

Trial Locations (1)

510080

Guangdong Provincial People's Hospital, Guangzhou

All Listed Sponsors

collaborator

Shantou Central Hospital

OTHER

collaborator

The First Affiliated Hospital of Clinical Medicine of Guangdong Pharmaceutical University

UNKNOWN

collaborator

First People's Hospital of Foshan

OTHER

lead

Guangdong Provincial People's Hospital

OTHER

NCT04909554 - MRI-based Approaches for Multi-parametric Model to Early Predict Pathological Complete Response to Neoadjuvant Therapy in Breast Cancer | Biotech Hunter | Biotech Hunter